Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of tDCS on Cannabis Craving in Schizophrenia
Sponsor: Centre hospitalier de Ville-Evrard, France
Summary
This study aims to evaluate the tDCS's impact on cannabis craving in patients with schizophrenia and cannabis addiction disorder.
Official title: Impact of tDCS on Cannabis Craving in Patients With Schizophrenia and Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
138
Start Date
2024-03-01
Completion Date
2027-06-20
Last Updated
2024-02-16
Healthy Volunteers
No
Conditions
Interventions
tDCS
tDCS will be delivered using this electrode montage: anode on the left dosolateral prefrontal cortex (L DLPFC) using F3 EEG landmark and cathode on the left temporoparietal junction (L TPJ) on the middle point between T3 and P3 EEG landmark. The stimulation will be delivered at an intensity of 2 milliamps, for 20 minutes, five times a day, with 20 min inter sessions (it will be carried out on 5 consecutive days from Monday to Friday). Each processing day corresponds to a visit of V2, V3, V4, V5 and V6.
Locations (2)
Ch Ville Evrard
Neuilly-sur-Marne, France
Youcef Bencherif
Neuilly-sur-Marne, France